| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 2.13e-09 | 38 | 189 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYO1G MYH9 MYO1D MYO1E MYO5A MYO5B MYO5C MYO3A KIF19 KIF17 DNAH8 | 1.62e-08 | 118 | 189 | 11 | GO:0003774 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYH9 SETX MYO1D MYO1E MYO5A MYO5B ATAD5 ATP9B MYO5C MYO3A MDN1 KIF19 NAV2 KIF17 DNAH8 HSPA7 HYOU1 MORC3 | 6.26e-06 | 614 | 189 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | MYO1G MYH9 MYO1D MYO1E MYO5A MYO5B RYR1 MYO5C MYO3A NOS3 EPB41 | 1.27e-05 | 230 | 189 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | actin binding | MYO1G MYH9 MYO1D MYO1E MYO5A MYO5B TPRN EPB41L3 MYO5C MYO3A FGD4 NOS3 KLHL5 EPB41 EPB41L1 EPB41L2 | 1.38e-05 | 479 | 189 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | cadherin binding | MYH9 CDH23 CEMIP2 PKP2 KDR NOS3 PPL ARVCF EPHA2 TNKS1BP1 PHLDB2 CDH17 | 9.80e-05 | 339 | 189 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.57e-04 | 33 | 189 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.23e-04 | 227 | 189 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | antigen binding | HLA-F IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 | 4.66e-04 | 190 | 189 | 8 | GO:0003823 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | MYH9 CDH23 CEMIP2 PTPRF PKP2 KDR NOS3 ITGA11 DSP PPL ARVCF EPHA2 TNKS1BP1 PHLDB2 CDH17 | 6.00e-04 | 599 | 189 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 7.23e-04 | 19 | 189 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G MYH9 MYO1D MYO1E MYO5A MYO5B TPRN EPB41L3 MYO5C MYO3A EML5 FGD4 KIF19 KIF17 NOS3 GIT1 KLHL5 IFT88 FARP1 EPB41 EPB41L1 EPB41L2 | 7.41e-04 | 1099 | 189 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication | 8.75e-04 | 5 | 189 | 2 | GO:0086083 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYO1E MYO5B ATAD5 ATP9B RABL3 MDN1 KIF19 NAV2 KIF17 DNAH8 GNL1 HSPA7 EFL1 RHOB ARHGAP5 RASEF MORC3 | 1.15e-03 | 775 | 189 | 17 | GO:0017111 |
| GeneOntologyCellularComponent | myosin complex | 6.50e-08 | 59 | 192 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYH9 MYO1D MYO1E MYO5B TPRN CDH23 ITPR3 MYO3A MME IFT88 TREH | 7.19e-06 | 223 | 192 | 11 | GO:0098862 |
| MousePheno | abnormal axon morphology | IREB2 EPB41L3 FIG4 FGD4 MME CNTNAP1 LAMA4 PARP10 ZNF24 LMNA VCAN EPHA7 | 9.97e-07 | 199 | 144 | 12 | MP:0005404 |
| Domain | Myosin_head_motor_dom | 2.43e-09 | 38 | 180 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.43e-09 | 38 | 180 | 8 | PS51456 | |
| Domain | Myosin_head | 2.43e-09 | 38 | 180 | 8 | PF00063 | |
| Domain | MYSc | 2.43e-09 | 38 | 180 | 8 | SM00242 | |
| Domain | 4_1_CTD | 8.35e-09 | 4 | 180 | 4 | PF05902 | |
| Domain | SAB | 8.35e-09 | 4 | 180 | 4 | PF04382 | |
| Domain | Band_4.1_C | 8.35e-09 | 4 | 180 | 4 | IPR008379 | |
| Domain | SAB_dom | 8.35e-09 | 4 | 180 | 4 | IPR007477 | |
| Domain | FA | 9.51e-08 | 13 | 180 | 5 | PF08736 | |
| Domain | FERM-adjacent | 9.51e-08 | 13 | 180 | 5 | IPR014847 | |
| Domain | FA | 9.51e-08 | 13 | 180 | 5 | SM01195 | |
| Domain | Ez/rad/moesin-like | 1.41e-06 | 21 | 180 | 5 | IPR000798 | |
| Domain | FERM_CS | 2.88e-06 | 24 | 180 | 5 | IPR019747 | |
| Domain | FERM_C | 4.39e-06 | 26 | 180 | 5 | PF09380 | |
| Domain | FERM_PH-like_C | 5.35e-06 | 27 | 180 | 5 | IPR018980 | |
| Domain | FERM_C | 5.35e-06 | 27 | 180 | 5 | SM01196 | |
| Domain | IQ | 5.43e-06 | 71 | 180 | 7 | PF00612 | |
| Domain | Myosin_S1_N | 8.68e-06 | 5 | 180 | 3 | IPR008989 | |
| Domain | FERM_N | 1.50e-05 | 33 | 180 | 5 | IPR018979 | |
| Domain | FERM_N | 1.50e-05 | 33 | 180 | 5 | PF09379 | |
| Domain | Dilute_dom | 1.72e-05 | 6 | 180 | 3 | IPR002710 | |
| Domain | DIL | 1.72e-05 | 6 | 180 | 3 | PF01843 | |
| Domain | DILUTE | 1.72e-05 | 6 | 180 | 3 | PS51126 | |
| Domain | DIL | 1.72e-05 | 6 | 180 | 3 | SM01132 | |
| Domain | P-loop_NTPase | MYO1G MYH9 SETX MYO1D MYO1E MYO5A MYO5B ATAD5 RABL3 MYO5C MYO3A MDN1 KIF19 GAL3ST3 NAV2 KIF17 DNAH8 GNL1 EFL1 RHOB ARHGAP5 RASEF | 2.34e-05 | 848 | 180 | 22 | IPR027417 |
| Domain | IQ_motif_EF-hand-BS | 2.62e-05 | 90 | 180 | 7 | IPR000048 | |
| Domain | Myosin_TH1 | 2.99e-05 | 7 | 180 | 3 | PF06017 | |
| Domain | Myosin_TH1 | 2.99e-05 | 7 | 180 | 3 | IPR010926 | |
| Domain | TH1 | 2.99e-05 | 7 | 180 | 3 | PS51757 | |
| Domain | IQ | 3.24e-05 | 93 | 180 | 7 | PS50096 | |
| Domain | - | 7.35e-05 | 73 | 180 | 6 | 2.60.120.260 | |
| Domain | FERM_M | 7.83e-05 | 46 | 180 | 5 | PF00373 | |
| Domain | - | 1.06e-04 | 49 | 180 | 5 | 1.20.80.10 | |
| Domain | FERM_central | 1.06e-04 | 49 | 180 | 5 | IPR019748 | |
| Domain | FERM_domain | 1.06e-04 | 49 | 180 | 5 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.17e-04 | 50 | 180 | 5 | IPR014352 | |
| Domain | FERM_1 | 1.17e-04 | 50 | 180 | 5 | PS00660 | |
| Domain | FERM_2 | 1.17e-04 | 50 | 180 | 5 | PS00661 | |
| Domain | FERM_3 | 1.17e-04 | 50 | 180 | 5 | PS50057 | |
| Domain | Band_41_domain | 1.17e-04 | 50 | 180 | 5 | IPR019749 | |
| Domain | B41 | 1.17e-04 | 50 | 180 | 5 | SM00295 | |
| Domain | IQ | 1.31e-04 | 81 | 180 | 6 | SM00015 | |
| Domain | VWFA | 1.41e-04 | 82 | 180 | 6 | PS50234 | |
| Domain | VWA | 1.61e-04 | 84 | 180 | 6 | SM00327 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.96e-04 | 14 | 180 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.96e-04 | 14 | 180 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.96e-04 | 14 | 180 | 3 | IPR001426 | |
| Domain | EphA2_TM | 2.96e-04 | 14 | 180 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.96e-04 | 14 | 180 | 3 | IPR001090 | |
| Domain | Eph_TM | 2.96e-04 | 14 | 180 | 3 | IPR027936 | |
| Domain | EPH_lbd | 2.96e-04 | 14 | 180 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 2.96e-04 | 14 | 180 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.96e-04 | 14 | 180 | 3 | IPR016257 | |
| Domain | EPH_LBD | 2.96e-04 | 14 | 180 | 3 | PS51550 | |
| Domain | Galactose-bd-like | 2.98e-04 | 94 | 180 | 6 | IPR008979 | |
| Domain | VWF_A | 3.94e-04 | 99 | 180 | 6 | IPR002035 | |
| Domain | CLZ | 5.47e-04 | 4 | 180 | 2 | PF16526 | |
| Domain | CLZ_dom | 5.47e-04 | 4 | 180 | 2 | IPR032406 | |
| Domain | - | 7.40e-04 | 74 | 180 | 5 | 3.40.50.410 | |
| Domain | EGF-like_CS | 9.93e-04 | 261 | 180 | 9 | IPR013032 | |
| Domain | EGF_2 | 1.10e-03 | 265 | 180 | 9 | PS01186 | |
| Domain | RIH_assoc-dom | 1.35e-03 | 6 | 180 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.35e-03 | 6 | 180 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.35e-03 | 6 | 180 | 2 | PF08454 | |
| Domain | RIH_dom | 1.35e-03 | 6 | 180 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.35e-03 | 6 | 180 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.35e-03 | 6 | 180 | 2 | IPR015925 | |
| Domain | - | 1.35e-03 | 6 | 180 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.35e-03 | 6 | 180 | 2 | PF01365 | |
| Domain | SAM | 1.62e-03 | 88 | 180 | 5 | SM00454 | |
| Domain | Ephrin_rec_like | 1.73e-03 | 25 | 180 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.73e-03 | 25 | 180 | 3 | IPR011641 | |
| Domain | Plectin | 1.88e-03 | 7 | 180 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.88e-03 | 7 | 180 | 2 | IPR001101 | |
| Domain | Plakophilin/d_Catenin | 1.88e-03 | 7 | 180 | 2 | IPR028435 | |
| Domain | PLEC | 1.88e-03 | 7 | 180 | 2 | SM00250 | |
| Domain | FN3 | 2.14e-03 | 185 | 180 | 7 | SM00060 | |
| Domain | SAM_DOMAIN | 2.26e-03 | 95 | 180 | 5 | PS50105 | |
| Domain | SAM | 2.48e-03 | 97 | 180 | 5 | IPR001660 | |
| Domain | FN3 | 3.22e-03 | 199 | 180 | 7 | PS50853 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 6.10e-07 | 53 | 133 | 7 | MM15716 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 8.17e-07 | 35 | 133 | 6 | MM17219 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.59e-06 | 39 | 133 | 6 | MM17212 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 3.79e-06 | 45 | 133 | 6 | MM14912 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 5.58e-06 | 48 | 133 | 6 | MM17214 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.12e-05 | 54 | 133 | 6 | MM14655 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | MYH9 MYO5A IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 | 1.21e-05 | 114 | 133 | 8 | MM14814 |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 1.25e-05 | 55 | 133 | 6 | M41823 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.39e-05 | 56 | 133 | 6 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.70e-05 | 58 | 133 | 6 | MM14914 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.08e-05 | 60 | 133 | 6 | MM14872 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 2.08e-05 | 60 | 133 | 6 | MM14913 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | PSMB8 ITPR3 IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 | 3.32e-05 | 131 | 133 | 8 | MM15717 |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | HLA-F IGHV3-64 COL2A1 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 | 4.12e-05 | 135 | 133 | 8 | MM14781 |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 6.76e-05 | 107 | 133 | 7 | MM14915 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 8.63e-05 | 77 | 133 | 6 | M41822 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.40e-04 | 84 | 133 | 6 | MM14653 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.50e-04 | 29 | 133 | 4 | M27309 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.70e-04 | 87 | 133 | 6 | M27617 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.91e-04 | 66 | 133 | 5 | M18 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 4.19e-04 | 67 | 133 | 5 | MM15327 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 5.13e-04 | 70 | 133 | 5 | M46438 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 5.46e-04 | 150 | 133 | 7 | MM14889 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 6.42e-04 | 42 | 133 | 4 | M39703 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 6.42e-04 | 42 | 133 | 4 | MM15822 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 7.03e-04 | 43 | 133 | 4 | M39565 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 7.44e-04 | 158 | 133 | 7 | MM14812 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.49e-04 | 76 | 133 | 5 | M27219 | |
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 1.38e-10 | 15 | 195 | 6 | 12657787 | |
| Pubmed | MYO5A RPN1 ATAD5 PIEZO1 KRI1 EPB41L3 RABL3 TTK LCMT2 CEMIP2 ITPR3 PM20D2 MDN1 WDR62 HYOU1 RPAP3 PMPCB POLE LAMC1 CHORDC1 TBL3 LMNA BAZ2A FARP1 EPHA2 MTR EMC2 SRRM2 EPB41L1 EPB41L2 EPHA7 | 2.92e-10 | 1487 | 195 | 31 | 33957083 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MYO1E RABL3 CEMIP2 CCNYL1 PTPRF NAV2 PKP2 PPFIBP2 OPTN ARVCF CSNK1A1 FARP1 EPHA2 EPB41 EPB41L1 EPB41L2 PHLDB2 EPHA3 EPHA7 | 6.43e-10 | 569 | 195 | 19 | 30639242 |
| Pubmed | 9.58e-10 | 4 | 195 | 4 | 15834631 | ||
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 1.99e-09 | 22 | 195 | 6 | 2499654 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX KDM3B EPB41L3 TTK CDCA2 MDN1 RNF10 NAV2 PKP2 WDR62 GIT1 DSP LAMC1 OPTN CSNK1A1 TNKS1BP1 MORC3 SRRM2 EPB41 EPB41L1 EPB41L2 PHLDB2 | 3.89e-09 | 861 | 195 | 22 | 36931259 |
| Pubmed | 4.77e-09 | 5 | 195 | 4 | 401950 | ||
| Pubmed | MYH9 MYO1D MYO5A KRI1 EPB41L3 ITPR3 MDN1 UTP20 HYOU1 POLR1A DSP POLE TBL3 LMNA BAZ2A RBM6 TNKS1BP1 SRRM2 EPB41L2 | 6.08e-09 | 653 | 195 | 19 | 22586326 | |
| Pubmed | MYO1D MYO5A MYO5B ATAD5 TPRN KRI1 CEMIP2 ITPR3 CDCA2 PTPRF GOLIM4 EFL1 HYOU1 RPAP3 PMPCB DSP XPO4 CACHD1 ARHGAP5 ARVCF FARP1 SRRM2 EPB41L1 PHLPP2 | 6.23e-09 | 1049 | 195 | 24 | 27880917 | |
| Pubmed | 1.01e-08 | 14 | 195 | 5 | 8022818 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYH9 RPN1 PIEZO1 HLA-F LMBRD2 LRP1B MYORG CEMIP2 BMP6 PTPRF BCAP29 GOLIM4 UTP20 WDR62 FAT4 ITGA11 HYOU1 CNTNAP1 LAMA4 LAMC1 CACHD1 CHORDC1 EPHA2 TNKS1BP1 EMC2 | 1.89e-08 | 1201 | 195 | 25 | 35696571 |
| Pubmed | KANSL1L RYR1 ADAMTS9 RNF10 MED12L MGA COL6A3 GIT1 DSP LAMA4 LAMC1 ZNF407 CHORDC1 OPTN LMNA UPF2 | 2.54e-08 | 497 | 195 | 16 | 23414517 | |
| Pubmed | 6.59e-08 | 8 | 195 | 4 | 7983158 | ||
| Pubmed | 8.04e-08 | 39 | 195 | 6 | 8490662 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3B EMSY MYO3A CCNYL1 MDN1 UTP20 WDR62 GIT1 DSP PPL STRIP1 LMNA BAZ2A RBM6 TNKS1BP1 SRRM2 EPB41L2 PHLDB2 CDH17 | 8.90e-08 | 774 | 195 | 19 | 15302935 |
| Pubmed | Protein 4.1 expression in the developing hair cells of the mouse inner ear. | 1.74e-07 | 3 | 195 | 3 | 19853587 | |
| Pubmed | Structural insights into the globular tails of the human type v myosins Myo5a, Myo5b, And Myo5c. | 1.74e-07 | 3 | 195 | 3 | 24339992 | |
| Pubmed | Structural insights into functional overlapping and differentiation among myosin V motors. | 1.74e-07 | 3 | 195 | 3 | 24097982 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 22429617 | ||
| Pubmed | CACUL1 RPN1 IREB2 RABL3 TTK CEMIP2 PKP2 YIPF3 HYOU1 LAMC1 SCAMP3 CACHD1 CHORDC1 GTF2B ZNF24 LMNA CSNK1A1 RBM6 EMC2 EPB41 EPB41L2 | 2.74e-07 | 1007 | 195 | 21 | 34597346 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D MYO5A MYO5B MYO5C ITPR3 MDN1 PTPRF UTP20 MGA HYOU1 POLR1A DSP LAMC1 SCAMP3 TBL3 ZNF24 LMNA EMC2 SRRM2 EPB41L2 PHLDB2 | 3.60e-07 | 1024 | 195 | 21 | 24711643 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH9 MYO1E MYO5A RPN1 TPRN MYO5C FAM111B ITPR3 PKP2 UTP20 HSPA7 SAMD1 POLR1A DSP TBL3 OPTN LMNA CSNK1A1 SRRM2 EPB41 | 4.55e-07 | 949 | 195 | 20 | 36574265 |
| Pubmed | Alternative splicing in class V myosins determines association with Rab10. | 6.91e-07 | 4 | 195 | 3 | 19008234 | |
| Pubmed | MYO1D ATAD5 KDM3B RABL3 RYR1 ITPR3 MDN1 FAT4 MXRA5 POLE MUC16 LAMC1 TBL3 RHOB ARVCF CDH17 | 7.33e-07 | 638 | 195 | 16 | 31182584 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 EPB41L3 TTK CEMIP2 NAV2 PKP2 PPL ARHGAP5 ARVCF CSNK1A1 EPHA2 TNKS1BP1 EPB41 EPB41L1 PHLDB2 | 8.15e-07 | 565 | 195 | 15 | 25468996 |
| Pubmed | The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. | IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 | 8.50e-07 | 91 | 195 | 7 | 9841928 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYH9 MYO1E MYO5A MYO5B LMBRD2 MDN1 PKP2 UTP20 YIPF3 HYOU1 PMPCB XPO4 CHORDC1 TBL3 GOLGA7 EMC2 PHLDB2 | 1.40e-06 | 754 | 195 | 17 | 33060197 |
| Pubmed | TPRN KDM3B ZNF518A PTPRF PKP2 ZNF107 MGA PLEKHB2 SMURF1 LAMA4 LAMC1 BTBD2 PPL ARHGAP5 OPTN | 1.42e-06 | 591 | 195 | 15 | 15231748 | |
| Pubmed | Band 4.1 proteins regulate integrin-dependent cell spreading. | 1.72e-06 | 5 | 195 | 3 | 22982319 | |
| Pubmed | The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. | 1.72e-06 | 5 | 195 | 3 | 22036564 | |
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 12574408 | ||
| Pubmed | MYO5A BTBD9 EPB41L3 GIT1 CNTNAP1 FAM81A ARVCF FARP1 EPB41L1 EPB41L2 | 1.73e-06 | 251 | 195 | 10 | 27507650 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYO1D KRI1 TTK LRP1B EMSY MGA WDR62 HYOU1 GIT1 RPAP3 DSP CHORDC1 ARHGAP5 CSNK1A1 FARP1 RASEF MORC3 EPB41 | 1.73e-06 | 853 | 195 | 18 | 28718761 |
| Pubmed | MYH9 MYO1D MYO1E MYO5A MYO5B RPN1 EPB41L3 FGD4 HYOU1 GIT1 DSP CNTNAP1 SMURF1 STRIP1 ARHGAP5 LMNA UPF2 ARVCF CSNK1A1 FARP1 VCAN TNKS1BP1 EPB41L1 EPB41L2 | 1.82e-06 | 1431 | 195 | 24 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 SETX MYO5A RPN1 EPB41L3 CDCA2 MDN1 PKP2 UTP20 MGA POLR1A RPAP3 PMPCB DSP POLE TBL3 LMNA UPF2 ARVCF BAZ2A SRRM2 EPB41L2 PHLDB2 | 2.42e-06 | 1353 | 195 | 23 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 MYO1D MYO1E MYO5A MYO5B RPN1 KRI1 ITPR3 PKP2 UTP20 HYOU1 RPAP3 PMPCB DSP TBL3 PPL LMNA UPF2 CSNK1A1 TNKS1BP1 EPB41L2 PHLDB2 | 2.56e-06 | 1257 | 195 | 22 | 36526897 |
| Pubmed | 2.76e-06 | 18 | 195 | 4 | 6788376 | ||
| Pubmed | 3.18e-06 | 210 | 195 | 9 | 16565220 | ||
| Pubmed | Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia. | 3.43e-06 | 6 | 195 | 3 | 12486594 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO1D MYO1E MYO5A ATAD5 EPB41L3 TTK MGA HYOU1 POLR1A GIT1 RPAP3 SMG5 ZNF24 UPF2 FARP1 EPHA2 | 3.73e-06 | 724 | 195 | 16 | 36232890 |
| Pubmed | Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. | 4.33e-06 | 20 | 195 | 4 | 9828140 | |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 4.90e-06 | 77 | 195 | 6 | 15608191 | |
| Pubmed | Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology. | 5.32e-06 | 21 | 195 | 4 | 26234751 | |
| Pubmed | MYH9 MYO5A TPRN ITPR3 POLR1A TBL3 LMNA CSNK1A1 FARP1 EPHA2 GOLGA7 TNKS1BP1 SRRM2 EPB41L2 PHLDB2 | 5.42e-06 | 660 | 195 | 15 | 32780723 | |
| Pubmed | D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. | 5.98e-06 | 7 | 195 | 3 | 12181426 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | RPN1 RABL3 ITPR3 PTPRF GOLIM4 UTP20 YIPF3 PLEKHB2 HYOU1 POLR1A POLE GALNT12 SCAMP3 CACHD1 TBL3 EPHA2 MTR EMC2 | 6.80e-06 | 942 | 195 | 18 | 31073040 |
| Pubmed | 7.41e-06 | 48 | 195 | 5 | 20301532 | ||
| Pubmed | 7.41e-06 | 48 | 195 | 5 | 8884266 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MYH9 SETX CACUL1 KDM3B EPB41L3 EMSY MGA RPAP3 GTF2B LMNA TNKS1BP1 EPB41L2 | 8.83e-06 | 444 | 195 | 12 | 34795231 |
| Pubmed | MYH9 SETX KDM3B EPB41L3 RABL3 CEMIP2 CDCA2 PKP2 MGA FAT4 MUC16 PPL STRIP1 EPHA2 EPB41 EPB41L2 | 9.01e-06 | 777 | 195 | 16 | 35844135 | |
| Pubmed | Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. | 9.52e-06 | 8 | 195 | 3 | 22568954 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | RPN1 EPB41L3 RABL3 LRP1B ITPR3 MDN1 BCAP29 PKP2 EMC2 EPB41 EPB41L2 | 9.85e-06 | 375 | 195 | 11 | 32788342 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MYO1D MYO1E MYO5A EPB41L3 PTPRF PMPCB SMURF1 LAMC1 EPHA2 MTR | 1.21e-05 | 313 | 195 | 10 | 38270169 |
| Pubmed | MYH9 RPN1 EPB41L3 TTK PKP2 HYOU1 RPAP3 DSP CACHD1 EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 EPHA3 | 1.24e-05 | 708 | 195 | 15 | 39231216 | |
| Pubmed | HLA-F PSMB8 TMEM63B BMP6 MDN1 FIG4 APOBEC2 DNAH8 YIPF3 MMS22L DSP LAMA4 UPF2 EPHA7 | 1.25e-05 | 622 | 195 | 14 | 14574404 | |
| Pubmed | 1.42e-05 | 9 | 195 | 3 | 11403717 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.56e-05 | 256 | 195 | 9 | 33397691 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RPN1 CEMIP2 ZNF518A PTPRF BCAP29 GOLIM4 MGA YIPF3 DSP CNTNAP1 LAMC1 ZNF407 SCAMP3 TBL3 STRIP1 ZNF24 LMNA GOLGA7 MORC3 SRRM2 | 1.58e-05 | 1203 | 195 | 20 | 29180619 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYO1G MYH9 MYO1D RPN1 HLA-F PSMB8 SORCS1 MDN1 HYOU1 DSP XPO4 LMNA RASEF TNKS1BP1 | 1.93e-05 | 647 | 195 | 14 | 26618866 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.00e-05 | 202 | 195 | 8 | 33005030 | |
| Pubmed | 2.02e-05 | 10 | 195 | 3 | 25073978 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 2.02e-05 | 10 | 195 | 3 | 16547242 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 2.38e-05 | 270 | 195 | 9 | 24366813 | |
| Pubmed | MYO5B BTBD9 EPB41L3 LCMT2 MYORG ADAMTS9 FIG4 MGA ZNF407 USP37 MORC3 EMC2 | 2.48e-05 | 493 | 195 | 12 | 15368895 | |
| Pubmed | 2.52e-05 | 272 | 195 | 9 | 31010829 | ||
| Pubmed | 2.77e-05 | 11 | 195 | 3 | 26644518 | ||
| Pubmed | 2.77e-05 | 11 | 195 | 3 | 15517401 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SETX CEMIP2 KDR DNAH8 MUC16 BBS10 EPHA2 SRRM2 EPB41L2 EPHA3 EPHA7 | 2.80e-05 | 420 | 195 | 11 | 28065597 |
| Pubmed | MYH9 SETX EPB41L3 NAV2 STRIP1 LMNA RBM6 TNKS1BP1 SRRM2 EPB41L1 EPB41L2 PHLDB2 | 3.02e-05 | 503 | 195 | 12 | 16964243 | |
| Pubmed | 3.07e-05 | 64 | 195 | 5 | 22261194 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX MYO1D TPRN TTK EMSY FAM111B GIT1 RNASEH2A DSP RBM6 MTR TNKS1BP1 MORC3 | 3.09e-05 | 588 | 195 | 13 | 38580884 |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 9598318 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 19272819 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 23109359 | ||
| Pubmed | Selective stimulation of VEGFR2 accelerates progressive renal disease. | 3.13e-05 | 2 | 195 | 2 | 21640973 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 19225127 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 29945963 | ||
| Pubmed | Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. | 3.13e-05 | 2 | 195 | 2 | 15731777 | |
| Pubmed | Human myosin-Vc is a novel class V myosin expressed in epithelial cells. | 3.13e-05 | 2 | 195 | 2 | 11870218 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 35348702 | ||
| Pubmed | Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. | 3.13e-05 | 2 | 195 | 2 | 34815391 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 25900994 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 15907481 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 10984423 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 11779193 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 18556578 | ||
| Pubmed | Matrix elasticity regulates lamin-A,C phosphorylation and turnover with feedback to actomyosin. | 3.13e-05 | 2 | 195 | 2 | 25127216 | |
| Pubmed | Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors. | 3.13e-05 | 2 | 195 | 2 | 21150295 | |
| Pubmed | Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin. | 3.13e-05 | 2 | 195 | 2 | 26912658 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 32348765 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 35163801 | ||
| Pubmed | MYH9 MYO5A BTBD9 EPB41L3 EMSY MDN1 MGA GIT1 CNTNAP1 FAM81A STRIP1 ARVCF CSNK1A1 FARP1 EPB41L1 EPB41L2 PHLDB2 | 3.36e-05 | 963 | 195 | 17 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYO5A TMEM63B ATP9B BTBD9 ALX4 BCAP29 MME ZNF107 MBLAC2 POLR1A PPFIBP2 SMURF1 ZBTB8A PARP10 PLXDC2 CSNK1A1 FARP1 RBM6 RASEF EPB41 EPB41L1 CPNE7 | 3.54e-05 | 1489 | 195 | 22 | 28611215 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 3.56e-05 | 219 | 195 | 8 | 31353912 | |
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 3.68e-05 | 12 | 195 | 3 | 21465626 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 3.68e-05 | 12 | 195 | 3 | 19247962 | |
| Pubmed | SETX MYO5A ATAD5 PIEZO1 RABL3 EMSY MDN1 FGD4 GOLIM4 UTP20 SAMD1 POLR1A TBL3 STRIP1 ZNF24 BAZ2A CSNK1A1 FARP1 RBM6 EPB41 EPB41L1 EPB41L2 | 3.83e-05 | 1497 | 195 | 22 | 31527615 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | IREB2 CCNYL1 MDN1 ADAMTS9 MGA COL6A3 MMS22L PRAMEF17 FARP1 EPHA7 | 4.26e-05 | 363 | 195 | 10 | 14691545 |
| Pubmed | 4.76e-05 | 13 | 195 | 3 | 16368544 | ||
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 4.76e-05 | 13 | 195 | 3 | 17039519 | |
| Interaction | C6orf141 interactions | 1.88e-07 | 92 | 187 | 9 | int:C6orf141 | |
| Interaction | C11orf52 interactions | MYO1D EPB41L3 CEMIP2 PTPRF PKP2 CACHD1 ARVCF FARP1 EPHA2 EPB41 EPB41L1 EPB41L2 PHLDB2 EPHA3 EPHA7 | 2.26e-07 | 311 | 187 | 15 | int:C11orf52 |
| Interaction | LYN interactions | MYH9 MYO1D MYO1E CDH23 EPB41L3 CEMIP2 PKP2 MME POLR1A DSP SH2D3C CACHD1 RHOB FARP1 EPHA2 TNKS1BP1 SRRM2 EPB41 EPB41L1 EPB41L2 PHLDB2 EPHA3 EPHA7 | 2.50e-07 | 720 | 187 | 23 | int:LYN |
| Interaction | RHOB interactions | MYO1D MYO1E RPN1 TTK CEMIP2 MDN1 SEMA6D PTPRF PKP2 UTP20 FAT4 SMURF1 SCAMP3 CACHD1 RHOB ARHGAP5 ARVCF CSNK1A1 FARP1 EPHA2 EMC2 EPB41L1 EPB41L2 PHLDB2 EPHA7 | 2.73e-07 | 840 | 187 | 25 | int:RHOB |
| Interaction | RAB35 interactions | MYO1D MYO5A RPN1 EPB41L3 RABL3 CEMIP2 PTPRF PKP2 SCAMP3 CACHD1 RHOB LMNA FARP1 EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 EPHA3 EPHA7 | 4.07e-07 | 573 | 187 | 20 | int:RAB35 |
| Interaction | GAGE5 interactions | 4.98e-07 | 52 | 187 | 7 | int:GAGE5 | |
| Interaction | OCLN interactions | MYO1D RPN1 EPB41L3 CEMIP2 PKP2 SMURF1 CACHD1 RHOB CSNK1A1 FARP1 EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 PHLDB2 EPHA7 | 4.47e-06 | 500 | 187 | 17 | int:OCLN |
| Interaction | CDH5 interactions | 8.08e-06 | 109 | 187 | 8 | int:CDH5 | |
| Interaction | TBCK interactions | 1.12e-05 | 82 | 187 | 7 | int:TBCK | |
| Interaction | MALL interactions | 1.13e-05 | 150 | 187 | 9 | int:MALL | |
| Interaction | SYNPO interactions | 1.28e-05 | 192 | 187 | 10 | int:SYNPO | |
| Interaction | CAV1 interactions | TMEM63B EPB41L3 RABL3 CEMIP2 ITPR3 PTPRF PKP2 KDR NOS3 YIPF3 CACHD1 RHOB LMNA ARVCF EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 EPHA7 | 1.39e-05 | 724 | 187 | 20 | int:CAV1 |
| Interaction | KRT222 interactions | 1.69e-05 | 35 | 187 | 5 | int:KRT222 | |
| Interaction | RAC3 interactions | MYO1E RPN1 EPB41L3 CEMIP2 PTPRF PKP2 UTP20 FAT4 GIT1 SCAMP3 ARHGAP5 FARP1 EPHA2 EMC2 EPB41L1 PHLDB2 EPHA3 EPHA7 | 1.95e-05 | 619 | 187 | 18 | int:RAC3 |
| Interaction | ITGB1 interactions | MYH9 RPN1 KDR DNAH8 ITGA11 RHOB ARHGAP5 LMNA UPF2 CSNK1A1 EPHA2 VCAN EMC2 CDH17 | 2.33e-05 | 400 | 187 | 14 | int:ITGB1 |
| Interaction | RHOD interactions | MYO5A RPN1 EPB41L3 RABL3 CEMIP2 ITPR3 MDN1 SEMA6D PTPRF UTP20 SCAMP3 ARHGAP5 FARP1 EPHA2 EMC2 EPB41 EPB41L1 | 2.55e-05 | 572 | 187 | 17 | int:RHOD |
| Interaction | RHOJ interactions | MYO1D MYO1E RPN1 EPB41L3 CEMIP2 MDN1 PTPRF PKP2 UTP20 GIT1 SCAMP3 CACHD1 ARHGAP5 FARP1 EPHA2 EPB41L1 PHLDB2 EPHA7 | 2.62e-05 | 633 | 187 | 18 | int:RHOJ |
| Interaction | ECT2 interactions | MYH9 MYO1D MYO1E MYO5B RPN1 TPRN KRI1 MYO5C PKP2 UTP20 MME HSPA7 SAMD1 ROGDI DSP TBL3 RHOB LMNA CSNK1A1 FARP1 SRRM2 PHLDB2 | 2.67e-05 | 887 | 187 | 22 | int:ECT2 |
| Interaction | CYFIP1 interactions | MYH9 MYO5A CDH23 EPB41L3 CNTNAP1 ARX RHOB CSNK1A1 FARP1 EPHA2 EPB41L1 EPHA7 | 2.75e-05 | 303 | 187 | 12 | int:CYFIP1 |
| Interaction | RAB11A interactions | MYH9 MYO1D MYO5A MYO5B KRI1 RABL3 CEMIP2 MYO5C ITPR3 PKP2 MME HYOU1 SCAMP3 CACHD1 RHOB OPTN EPHA2 RASEF TNKS1BP1 EPB41 EPB41L1 | 3.09e-05 | 830 | 187 | 21 | int:RAB11A |
| Interaction | RHOC interactions | MYO1E RPN1 RABL3 CEMIP2 PTPRF UTP20 FAT4 RHOB ARHGAP5 LMNA FARP1 EPHA2 GOLGA7 EMC2 EPB41L1 PHLDB2 EPHA7 | 3.31e-05 | 584 | 187 | 17 | int:RHOC |
| Interaction | CCDC8 interactions | MYO1D MYO5A MYO5B MYO5C ITPR3 MDN1 UTP20 POLR1A DSP LAMC1 SCAMP3 RHOB ZNF24 LMNA EPHA2 EMC2 EPB41L2 PHLDB2 | 4.18e-05 | 656 | 187 | 18 | int:CCDC8 |
| Interaction | LRRIQ1 interactions | 4.71e-05 | 43 | 187 | 5 | int:LRRIQ1 | |
| Interaction | RHOF interactions | MYO1D MYO1E MYO5A RPN1 EPB41L3 CEMIP2 MDN1 SEMA6D PTPRF UTP20 FAT4 ARHGAP5 ARVCF FARP1 EPHA2 EMC2 EPB41 EPB41L1 | 5.81e-05 | 673 | 187 | 18 | int:RHOF |
| Interaction | SIRT7 interactions | MYH9 MYO1D MYO5A KRI1 EPB41L3 ITPR3 MDN1 UTP20 HYOU1 POLR1A DSP POLE TBL3 LMNA BAZ2A RBM6 TNKS1BP1 SRRM2 EPB41L2 | 6.65e-05 | 744 | 187 | 19 | int:SIRT7 |
| Interaction | GJA1 interactions | MYO1D RPN1 RABL3 CEMIP2 ITPR3 PKP2 SCAMP3 CACHD1 RHOB LMNA FARP1 EPHA2 EPB41L1 EPB41L2 PHLDB2 EPHA3 | 1.13e-04 | 583 | 187 | 16 | int:GJA1 |
| Interaction | ARF6 interactions | RPN1 EPB41L3 CEMIP2 PTPRF PKP2 GIT1 SCAMP3 CACHD1 RHOB FARP1 EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 EPHA7 | 1.15e-04 | 584 | 187 | 16 | int:ARF6 |
| Interaction | KLHL1 interactions | 1.23e-04 | 28 | 187 | 4 | int:KLHL1 | |
| Interaction | RAC1 interactions | MYH9 MYO1E MYO5B RPN1 EPB41L3 CEMIP2 MDN1 SEMA6D PTPRF PKP2 UTP20 GIT1 RHOB ARHGAP5 OPTN CSNK1A1 FARP1 EPHA2 GOLGA7 EMC2 EPB41L1 PHLDB2 EPHA7 | 1.39e-04 | 1063 | 187 | 23 | int:RAC1 |
| Interaction | FLOT1 interactions | MYH9 MYO1D TMEM63B IRF1 EPB41L3 PKP2 RHOB FARP1 EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 PHLDB2 | 1.47e-04 | 475 | 187 | 14 | int:FLOT1 |
| Interaction | MARCKS interactions | MYO1D RPN1 EPB41L3 RABL3 CEMIP2 PKP2 SCAMP3 CACHD1 RHOB FARP1 EPHA2 TNKS1BP1 EPB41 EPB41L1 EPB41L2 EPHA7 | 1.60e-04 | 601 | 187 | 16 | int:MARCKS |
| Cytoband | 14q32.33 | IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 | 5.88e-05 | 228 | 195 | 7 | 14q32.33 |
| Cytoband | 6p21 | 1.05e-04 | 57 | 195 | 4 | 6p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 3.28e-04 | 503 | 195 | 9 | chr6p21 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 3.54e-09 | 4 | 141 | 4 | 951 | |
| GeneFamily | Myosins, class V | 4.64e-07 | 3 | 141 | 3 | 1100 | |
| GeneFamily | Myosins, class I | 2.53e-05 | 8 | 141 | 3 | 1097 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.29e-05 | 50 | 141 | 5 | 1293 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.59e-04 | 14 | 141 | 3 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 6.26e-04 | 88 | 141 | 5 | 760 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 | 6.67e-04 | 187 | 141 | 7 | 349 |
| GeneFamily | Fibronectin type III domain containing | 1.60e-03 | 160 | 141 | 6 | 555 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.64e-03 | 8 | 141 | 2 | 939 | |
| GeneFamily | Cyclic nucleotide gated channels | 2.61e-03 | 10 | 141 | 2 | 250 | |
| GeneFamily | Laminin subunits | 3.79e-03 | 12 | 141 | 2 | 626 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.01e-03 | 134 | 141 | 5 | 861 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | GHR PKP2 IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 DSP | 6.13e-08 | 102 | 191 | 9 | MM872 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | MYH9 IRF1 ALX4 BCAP29 GOLIM4 COL6A3 MXRA5 LAMA4 LAMC1 SNED1 VCAN EPB41L2 PHLDB2 EPHA3 EPHA7 | 1.67e-07 | 385 | 191 | 15 | M39264 |
| Coexpression | XU_CREBBP_TARGETS_DN | 3.32e-06 | 56 | 191 | 6 | MM642 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | ATAD5 CDCA2 BMP6 MDN1 BCAP29 ZNF107 SAMD1 MMS22L POLE ZBTB8A FAM81A UPF2 RAVER2 PHLDB2 | 6.70e-06 | 454 | 191 | 14 | M19927 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PI4K2B SETX MYO5A EPB41L3 TTK BCAP29 ETAA1 GOLIM4 ZNF107 RPAP3 CENPU ZNF407 CHORDC1 ARHGAP5 OPTN MTR EMC2 | 6.90e-06 | 656 | 191 | 17 | M18979 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | MYH9 PIEZO1 IRF1 MYORG CEMIP2 MYO5C ITPR3 MDN1 SAT1 BCAP29 KDR NOS3 DSP SH2D3C LAMA4 LAMC1 RHOB BCL6B KLHL5 EPHA2 | 8.40e-06 | 888 | 191 | 20 | M39049 |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.50e-05 | 43 | 191 | 5 | M1551 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.50e-05 | 43 | 191 | 5 | MM666 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | MYH9 GOLIM4 ITGA11 PPFIBP2 SH2D3C LAMA4 LAMC1 LMNA FARP1 TNKS1BP1 EPB41L1 | 1.50e-05 | 303 | 191 | 11 | M39040 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 1.51e-05 | 197 | 191 | 9 | M3438 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.71e-05 | 200 | 191 | 9 | M7529 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 1.71e-05 | 200 | 191 | 9 | M6484 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | MYH9 MYO1E BCAP29 MME FAT4 PPL ARHGAP5 KLHL5 OPTN RASEF EPB41 EPB41L2 PHLDB2 EPHA7 | 2.15e-05 | 504 | 191 | 14 | M2157 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.60e-05 | 162 | 191 | 8 | M45037 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.74e-05 | 221 | 191 | 9 | M39222 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | 5.35e-05 | 132 | 191 | 7 | MM996 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 8.03e-05 | 244 | 191 | 9 | M40312 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.11e-04 | 199 | 191 | 8 | M5893 | |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 1.15e-04 | 200 | 191 | 8 | M3390 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP | 1.15e-04 | 200 | 191 | 8 | M9060 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | SETX ESRP1 MEIOB TTK ZNF518A CDCA2 MDN1 BCAP29 ETAA1 MED12L PKP2 UTP20 DNAH8 MMS22L RPAP3 DSP POLE CENPU XPO4 USP37 BAZ2A MTR MORC3 | 1.22e-06 | 822 | 189 | 23 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | MYO5B CEMIP2 SEMA6D PTPRF ADAMTS9 FGD4 NAV2 PKP2 MME CNGA1 CYP26B1 DSP PPFIBP2 LAMA4 CACHD1 FARP1 VCAN MTR RASEF EPB41L1 PHLDB2 EPHA7 | 5.79e-06 | 837 | 189 | 22 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | CDH23 CEMIP2 PTPRF ADAMTS9 FGD4 KIF19 NAV2 PKP2 MME CNGA1 ITGA11 CYP26B1 HYOU1 POLR1A DSP PPFIBP2 LAMA4 USP37 FARP1 VCAN MTR EPHA7 | 1.36e-05 | 884 | 189 | 22 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | MYH9 SETX EPB41L3 GHR MME LAMA4 LAMC1 CSNK1A1 VCAN EPB41 EPHA3 EPHA7 | 2.46e-05 | 312 | 189 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | KANSL1L MYO5B PIEZO1 LCMT2 SEMA6D ADAMTS9 FIG4 FGD4 NAV2 PKP2 FAT4 DSP MUC16 CACHD1 KLHL5 MTR RASEF MORC3 EPB41L1 EPHA7 | 2.75e-05 | 791 | 189 | 20 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MYO1D TTK GHR ADAMTS9 MME CNGA1 COL6A3 ITGA11 DSP PPFIBP2 POLE ARX CENPU MUC16 PLXDC2 FARP1 VCAN RAVER2 EPHA3 EPHA7 | 2.85e-05 | 793 | 189 | 20 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | SETX ESRP1 TTK ZNF518A CDCA2 MDN1 BCAP29 ETAA1 PKP2 UTP20 MMS22L RPAP3 POLE CENPU XPO4 USP37 OPTN BAZ2A MTR MORC3 | 2.95e-05 | 795 | 189 | 20 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | SETX ESRP1 TTK CEMIP2 MYO5C CDCA2 MDN1 BCAP29 ETAA1 PKP2 UTP20 DNAH8 MMS22L DSP POLE CENPU XPO4 BAZ2A MTR MORC3 | 3.16e-05 | 799 | 189 | 20 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_200 | 3.35e-05 | 179 | 189 | 9 | gudmap_kidney_adult_Podocyte_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | SETX ESRP1 IRF1 TTK ZNF518A CDCA2 MDN1 EML5 BCAP29 PKP2 UTP20 MGA RPAP3 POLE XPO4 OPTN IFT88 BAZ2A MTR MORC3 | 3.83e-05 | 810 | 189 | 20 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | MYO5B ESRP1 CEMIP2 EML5 PTPRF ADAMTS9 FGD4 MED12L NAV2 PKP2 COL2A1 DSP RAVER2 RASEF EPB41 | 3.92e-05 | 495 | 189 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_500 | MYO1D MYO1E GOLIM4 PKP2 MME MBLAC2 PPFIBP2 FAM81A ARHGAP5 OPTN PLXDC2 ARVCF RAVER2 EMC2 | 4.78e-05 | 445 | 189 | 14 | gudmap_kidney_adult_Podocyte_MafB_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | SETX ESRP1 TTK CDCA2 MDN1 BCAP29 ETAA1 UTP20 MMS22L CENPU XPO4 BAZ2A MTR MORC3 | 7.30e-05 | 463 | 189 | 14 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | SETX ESRP1 TTK ZNF518A CDCA2 MDN1 BCAP29 ETAA1 PKP2 UTP20 VPREB1 MMS22L DSP POLE CENPU XPO4 BAZ2A MTR MORC3 | 7.35e-05 | 781 | 189 | 19 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | MYO5B EPB41L3 GHR SEMA6D NAV2 MME COL6A3 FAT4 POLR1A MUC16 CACHD1 KLHL5 PLXDC2 VCAN RAVER2 MTR EPB41L1 EPHA3 EPHA7 | 9.59e-05 | 797 | 189 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SETX ESRP1 MEIOB EPB41L3 TTK ZNF518A MDN1 EML5 BCAP29 MED12L MGA DNAH8 MMS22L DSP POLE USP37 BAZ2A MTR MORC3 | 1.39e-04 | 820 | 189 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.42e-04 | 266 | 189 | 10 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MYO5B TTK GHR SEMA6D ADAMTS9 KDR MME CNGA1 COL6A3 VPREB1 MMS22L PPFIBP2 MUC16 CACHD1 FARP1 VCAN MTR PHLDB2 EPHA7 | 1.55e-04 | 827 | 189 | 19 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | KANSL1L EPB41L3 BMP6 RTL9 MME TMEM236 COL2A1 FAT4 ITGA11 CYP26B1 PPFIBP2 LAMA4 CACHD1 SNED1 EPB41 | 1.77e-04 | 567 | 189 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | ATAD5 PIEZO1 GHR PTPRF ADAMTS9 MME CNGA1 COL6A3 DSP PPFIBP2 MUC16 PLXDC2 FARP1 VCAN RAVER2 EPB41L2 EPHA3 EPHA7 | 1.82e-04 | 768 | 189 | 18 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | MYH9 MYO1D MYO1E GOLIM4 PKP2 MME PLEKHB2 MBLAC2 PPFIBP2 ZBTB8A FAM81A ARHGAP5 OPTN PLXDC2 ARVCF CSNK1A1 EPHA2 RAVER2 EMC2 | 1.83e-04 | 838 | 189 | 19 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | MYO5B ESRP1 CEMIP2 EML5 PTPRF ADAMTS9 FGD4 MED12L NAV2 PKP2 MME COL2A1 COL6A3 CYP26B1 DSP SNED1 RAVER2 RASEF EPB41 EPB41L1 EPHA3 | 1.91e-04 | 984 | 189 | 21 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | KANSL1L EPB41L3 ALX4 BMP6 RTL9 MME TMEM236 COL6A3 FAT4 ITGA11 CYP26B1 PPFIBP2 LAMA4 CACHD1 SNED1 EPHA7 | 2.12e-04 | 642 | 189 | 16 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | MYO1G ATAD5 TPRN BTBD9 RABL3 TTK EMSY ZNF518A CDCA2 CCNYL1 MDN1 EML5 ETAA1 NAV2 UTP20 MGA YIPF3 WDR62 DONSON RPAP3 CENPU TBL3 ARHGAP5 RAVER2 SRRM2 EPHA7 | 2.13e-04 | 1371 | 189 | 26 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | MYO5B ESRP1 EPB41L3 MYO5C CDCA2 PTPRF FIG4 FGD4 PKP2 PLEKHB2 DSP PPFIBP2 PPL KLHL5 B4GALNT2 RASEF EPB41L1 CDH17 | 2.19e-04 | 780 | 189 | 18 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | KANSL1L EPB41L3 BMP6 RTL9 MME TMEM236 COL6A3 FAT4 ITGA11 CYP26B1 LAMA4 CACHD1 SNED1 EPB41 EPB41L1 EPHA7 | 2.65e-04 | 655 | 189 | 16 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | EPB41L3 TTK RTL9 UTP20 MME TMEM236 ITGA11 CYP26B1 LAMA4 CACHD1 SNED1 LMNA EPB41 EPB41L1 EPHA7 | 3.02e-04 | 596 | 189 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SETX MYO5B ATAD5 TTK ZNF518A CDCA2 EML5 ETAA1 DONSON RPAP3 POLE USP37 RBM6 EPB41 | 3.07e-04 | 532 | 189 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#3 | 3.12e-04 | 144 | 189 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 3.57e-04 | 194 | 189 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 3.84e-04 | 149 | 189 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.31e-04 | 251 | 189 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.31e-04 | 251 | 189 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k1 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | MYH9 MYO1D PIEZO1 ESRP1 MYORG ITPR3 SAT1 ADAMTS9 ZNF479 ANO4 COL6A3 ITGA11 DSP LAMC1 VCAN PHLDB2 CDH17 | 4.77e-04 | 761 | 189 | 17 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 5.52e-04 | 75 | 189 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.53e-04 | 114 | 189 | 6 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MYO1D TTK GHR ADAMTS9 MME COL6A3 PPFIBP2 POLE ARX CENPU MUC16 PLXDC2 VCAN RAVER2 EPB41L2 EPHA3 EPHA7 | 6.03e-04 | 777 | 189 | 17 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | CDH23 PTPRF ADAMTS9 MME CNGA1 ITGA11 CYP26B1 DSP PPFIBP2 LAMA4 FARP1 VCAN | 6.17e-04 | 441 | 189 | 12 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | 6.56e-04 | 163 | 189 | 7 | Arv_SC-hpx_blastocyst_500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | MYO5B GHR SEMA6D PTPRF ADAMTS9 NAV2 MME COL6A3 FAT4 MUC16 CACHD1 KLHL5 PLXDC2 FARP1 VCAN MTR EPHA7 | 6.56e-04 | 783 | 189 | 17 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_500 | 6.81e-04 | 45 | 189 | 4 | gudmap_kidney_adult_Mesangium_Meis_k1_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | KANSL1L SETX ATAD5 TTK EMSY ZNF518A CDCA2 CCNYL1 MDN1 RNF10 ETAA1 COL2A1 PMPCB PPFIBP2 POLE CHORDC1 SNED1 ARHGAP5 OPTN PLXDC2 VCAN EPB41 EPHA3 | 6.94e-04 | 1241 | 189 | 23 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | MYH9 IRF1 EPB41L3 GHR BMP6 CCNYL1 BCAP29 KDR KIF17 NOS3 FAT4 CNTNAP1 SH2D3C LAMA4 LAMC1 RHOB BCL6B SNED1 LMNA | 7.15e-04 | 936 | 189 | 19 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | MYO5B SEMA6D ADAMTS9 MME COL6A3 FAT4 MUC16 KLHL5 VCAN MTR EPHA7 | 7.43e-04 | 388 | 189 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 7.90e-04 | 122 | 189 | 6 | gudmap_kidney_adult_Podocyte_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | MYO5B EPB41L3 GHR SEMA6D NAV2 MME COL6A3 FAT4 MUC16 CACHD1 KLHL5 PLXDC2 VCAN MTR EPB41L1 EPHA3 EPHA7 | 7.99e-04 | 797 | 189 | 17 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | KANSL1L EPB41L3 BMP6 RTL9 MME CNGA1 TMEM236 COL6A3 FAT4 ITGA11 CYP26B1 PPFIBP2 CACHD1 SNED1 EPB41L1 EPHA7 | 8.08e-04 | 726 | 189 | 16 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | KANSL1L EPB41L3 ALX4 RTL9 TMEM236 COL2A1 FAT4 ITGA11 CYP26B1 PPFIBP2 LAMA4 CACHD1 SNED1 EPHA7 | 8.37e-04 | 589 | 189 | 14 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | MYH9 SETX MYO5B ESRP1 MYO5C CDCA2 EML5 FGD4 MED12L PKP2 MME LAMC1 GALNT12 FAM81A ZNF24 ARVCF EPB41 | 8.44e-04 | 801 | 189 | 17 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | KANSL1L EPB41L3 BMP6 RTL9 MME TMEM236 COL6A3 FAT4 ITGA11 CYP26B1 SNED1 LMNA EPB41L1 EPHA7 | 8.65e-04 | 591 | 189 | 14 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | MYO1G KANSL1L EPB41L3 GHR RTL9 MME KIF17 TMEM236 COL6A3 PIGB FAT4 ITGA11 CYP26B1 PPFIBP2 LAMA4 SNED1 LMNA EPB41L1 | 8.84e-04 | 878 | 189 | 18 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.97e-04 | 125 | 189 | 6 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | ZNF229 CEMIP2 CDCA2 ADAMTS9 NAV2 KDR MGA CNGA1 CYP26B1 HYOU1 POLR1A ARX XPO4 GTF2B RBM6 MTR EPB41L2 | 9.03e-04 | 806 | 189 | 17 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | CDH23 CEMIP2 PTPRF ADAMTS9 FGD4 NAV2 MME CNGA1 ITGA11 CYP26B1 POLR1A DSP PPFIBP2 LAMA4 USP37 FARP1 VCAN EPHA7 | 9.07e-04 | 880 | 189 | 18 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | MYO1E ATAD5 TTK CDCA2 NAV2 DNAH8 MMS22L POLE CNTNAP1 FARP1 RAVER2 | 9.14e-04 | 398 | 189 | 11 | GSM538338_500 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | 9.96e-04 | 175 | 189 | 7 | Arv_SC-H9hpx_500_K3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 9.96e-04 | 175 | 189 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.00e-03 | 227 | 189 | 8 | gudmap_kidney_adult_RenCorpuscGlomer_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#1_top-relative-expression-ranked_200 | 1.03e-03 | 86 | 189 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | KANSL1L SETX EPB41L3 TTK BMP6 RTL9 MME TMEM236 COL2A1 COL6A3 FAT4 ITGA11 CYP26B1 LAMA4 SNED1 EPB41L1 | 1.04e-03 | 744 | 189 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SETX ATAD5 TTK ZNF518A MYO3A CCNYL1 ETAA1 POLE UPF2 RBM6 MORC3 EPB41 | 1.05e-03 | 469 | 189 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GHR NAV2 COL2A1 COL6A3 FAT4 LAMA4 LAMC1 SNED1 PLXDC2 VCAN EPB41L2 PHLDB2 | 9.38e-11 | 200 | 195 | 12 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GHR NAV2 COL6A3 FAT4 ITGA11 LAMA4 LAMC1 SNED1 PLXDC2 VCAN EPB41L2 PHLDB2 | 9.38e-11 | 200 | 195 | 12 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D MYO1E MYO5B LRP1B MYO5C ITPR3 FGD4 NAV2 LAMA4 PPL EPHA2 | 7.14e-10 | 187 | 195 | 11 | 42a1267bfc27b4460b8409ada580a87c4385841c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D MYO1E MYO5B LRP1B MYO5C ITPR3 FGD4 NAV2 LAMA4 PPL EPHA2 | 7.14e-10 | 187 | 195 | 11 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO1D MYO5B EPB41L3 MYO5C PTPRF NAV2 DSP PPL FARP1 TNKS1BP1 PHLDB2 | 7.14e-10 | 187 | 195 | 11 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D MYO1E MYO5B LRP1B MYO5C ITPR3 FGD4 NAV2 LAMA4 PPL EPHA2 | 7.14e-10 | 187 | 195 | 11 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | MYO5B ESRP1 MYO5C FAM111B ITPR3 MYO3A EML5 PTPRF FGD4 COL2A1 RASEF | 9.44e-10 | 192 | 195 | 11 | d3634574b2e8d2ded6446969361b70761b331aea |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | MYO1D RPN1 IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 LAMC1 | 9.98e-10 | 193 | 195 | 11 | 7b4b0271e4fbece703876acb053ae236afb7cdba |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL6A3 FAT4 ITGA11 LAMA4 LAMC1 SNED1 PLXDC2 VCAN EPB41L2 PHLDB2 EPHA3 | 1.11e-09 | 195 | 195 | 11 | f54bc4454270ff06e85596f98199372b50d0179f |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYO1D MYO5B TMEM63B MYO5C PTPRF NAV2 DSP LAMC1 PPL FARP1 PHLDB2 | 1.38e-09 | 199 | 195 | 11 | d43c605a4ff221cf78d91678c15d2ad20f831c7f |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GHR NAV2 COL6A3 FAT4 LAMA4 LAMC1 SNED1 PLXDC2 VCAN EPB41L2 PHLDB2 | 1.45e-09 | 200 | 195 | 11 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-09 | 181 | 195 | 10 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-08 | 186 | 195 | 10 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-08 | 193 | 195 | 10 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.69e-08 | 196 | 195 | 10 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | RPN1 IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 LAMC1 | 1.69e-08 | 196 | 195 | 10 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | MYO1D RPN1 IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 LAMC1 | 1.77e-08 | 197 | 195 | 10 | 1e63879633f20646e44873ae6b662f6faf4806fd |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.86e-08 | 198 | 195 | 10 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | MYO1D RPN1 IGHV3-64 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 LAMC1 | 1.86e-08 | 198 | 195 | 10 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYO1D MYO5B TMEM63B EPB41L3 MYO5C PTPRF NAV2 DSP FARP1 PHLDB2 | 2.04e-08 | 200 | 195 | 10 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.04e-08 | 200 | 195 | 10 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | MYO5B TMEM63B EPB41L3 MYO5C EML5 PTPRF NAV2 DSP FARP1 PHLDB2 | 2.04e-08 | 200 | 195 | 10 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-08 | 200 | 195 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-08 | 169 | 195 | 9 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-07 | 180 | 195 | 9 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 182 | 195 | 9 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 182 | 195 | 9 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 182 | 195 | 9 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.22e-07 | 183 | 195 | 9 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-07 | 183 | 195 | 9 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-07 | 185 | 195 | 9 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-07 | 186 | 195 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYO1D IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 LAMC1 | 1.60e-07 | 189 | 195 | 9 | 73ee4cfb1057832f700be59b6917dedde3e89880 |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYO1D IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 LAMC1 | 1.60e-07 | 189 | 195 | 9 | f2daf4889ef98bbefe3e44832618ac102a75b4d9 |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-07 | 189 | 195 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYO1D IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 LAMC1 | 1.60e-07 | 189 | 195 | 9 | a1bda6ed5c52a5d33d229018cb5982cae6305533 |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-07 | 191 | 195 | 9 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-07 | 191 | 195 | 9 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.83e-07 | 192 | 195 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.83e-07 | 192 | 195 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 194 | 195 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.00e-07 | 194 | 195 | 9 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.00e-07 | 194 | 195 | 9 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-07 | 195 | 195 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 197 | 195 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.38e-07 | 198 | 195 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-07 | 198 | 195 | 9 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-07 | 198 | 195 | 9 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.48e-07 | 199 | 195 | 9 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.48e-07 | 199 | 195 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-07 | 199 | 195 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 199 | 195 | 9 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-07 | 199 | 195 | 9 | a697b3f0760e66bad8ea8d83cf6fea5934692c56 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 199 | 195 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 199 | 195 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-07 | 199 | 195 | 9 | bdedcc7c8f3be0996200c882dda82fb2658655c0 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 200 | 195 | 9 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.59e-07 | 200 | 195 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.59e-07 | 200 | 195 | 9 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-07 | 200 | 195 | 9 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.59e-07 | 200 | 195 | 9 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.59e-07 | 200 | 195 | 9 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 200 | 195 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.59e-07 | 200 | 195 | 9 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | severe-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.59e-07 | 200 | 195 | 9 | 23e3d2fb86a71f62cca32640842fbba5dd163453 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 200 | 195 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-07 | 200 | 195 | 9 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-07 | 162 | 195 | 8 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-07 | 162 | 195 | 8 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.24e-07 | 166 | 195 | 8 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DNAH8 CNGA1 IGHV3-64 IGHV3-48 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 | 8.29e-07 | 169 | 195 | 8 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.67e-07 | 170 | 195 | 8 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 174 | 195 | 8 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 178 | 195 | 8 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 178 | 195 | 8 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 178 | 195 | 8 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.23e-06 | 178 | 195 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 178 | 195 | 8 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-06 | 179 | 195 | 8 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-06 | 179 | 195 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYO1D IGHV3-64 IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 | 1.28e-06 | 179 | 195 | 8 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.51e-06 | 183 | 195 | 8 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-06 | 184 | 195 | 8 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-06 | 184 | 195 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-06 | 185 | 195 | 8 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 186 | 195 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 187 | 195 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 1.77e-06 | 187 | 195 | 8 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 187 | 195 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 187 | 195 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.77e-06 | 187 | 195 | 8 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-06 | 188 | 195 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-06 | 188 | 195 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 188 | 195 | 8 | b1049003ca79c340bb8c78da66bdc0956e1aebc2 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 188 | 195 | 8 | 3dd571bd8e7358b4346dea71f6bf9602dabf583c | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.84e-06 | 188 | 195 | 8 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 189 | 195 | 8 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | MYO1D IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 LAMC1 | 1.92e-06 | 189 | 195 | 8 | c296660061b46e3abae1e7cf29df20274e5a8add |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.92e-06 | 189 | 195 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | MYO1D IGHV3-48 IGHV3-21 HYOU1 IGHV3-20 IGHV3-11 IGHV3-7 LAMC1 | 1.92e-06 | 189 | 195 | 8 | 31594cc59eb1c5b01407dfd72b1487ecca8bf5ec |
| Drug | formycin triphosphate | 1.66e-07 | 51 | 183 | 7 | CID000122274 | |
| Drug | purealin | 4.11e-07 | 58 | 183 | 7 | CID006419303 | |
| Drug | blebbistatin | 4.53e-06 | 116 | 183 | 8 | CID003476986 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 1.60e-05 | 25 | 182 | 4 | DOID:0050589 (implicated_via_orthology) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 2.68e-05 | 10 | 182 | 3 | DOID:0050431 (is_implicated_in) | |
| Disease | non-syndromic X-linked intellectual disability 1 (implicated_via_orthology) | 3.78e-05 | 2 | 182 | 2 | DOID:0112038 (implicated_via_orthology) | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 6.31e-05 | 13 | 182 | 3 | EFO_0010617 | |
| Disease | body weights and measures | 8.77e-05 | 38 | 182 | 4 | EFO_0004324 | |
| Disease | Charcot-Marie-Tooth disease | 1.31e-04 | 42 | 182 | 4 | cv:C0007959 | |
| Disease | Amyotrophic lateral sclerosis | 1.47e-04 | 17 | 182 | 3 | cv:C0002736 | |
| Disease | Cardiomyopathy | 2.03e-04 | 47 | 182 | 4 | cv:C0878544 | |
| Disease | cognitive function measurement | PIEZO1 HLA-F IREB2 LMBRD2 LRP1B MYO3A SEMA6D PTPRF FGD4 RNF10 MED12L EFL1 MMS22L DSP XPO4 STRIP1 FARP1 RBM6 CDH17 CPNE7 EPHA7 | 2.20e-04 | 1434 | 182 | 21 | EFO_0008354 |
| Disease | Hyaloideoretinal degeneration of Wagner | 2.25e-04 | 4 | 182 | 2 | C1840452 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.24e-04 | 148 | 182 | 6 | C0279702 | |
| Disease | Carcinoma of lung | 3.73e-04 | 23 | 182 | 3 | C0684249 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.73e-04 | 152 | 182 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | neurilemmoma (is_marker_for) | 3.74e-04 | 5 | 182 | 2 | DOID:3192 (is_marker_for) | |
| Disease | gastroesophageal reflux disease | 4.15e-04 | 101 | 182 | 5 | EFO_0003948 | |
| Disease | Colorectal Carcinoma | CACUL1 BMP6 ETAA1 KDR DNAH8 DONSON POLE LAMC1 GALNT12 GTF2B B4GALNT2 EPHA3 EPHA7 | 4.43e-04 | 702 | 182 | 13 | C0009402 |
| Disease | platelet-to-lymphocyte ratio | 4.48e-04 | 363 | 182 | 9 | EFO_0008446 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 5.44e-04 | 227 | 182 | 7 | EFO_0004346, EFO_0010736 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 5.58e-04 | 6 | 182 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Dupuytren Contracture | 5.64e-04 | 108 | 182 | 5 | EFO_0004229 | |
| Disease | pancreatic cancer (is_implicated_in) | 6.65e-04 | 112 | 182 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Drug habituation | 7.50e-04 | 115 | 182 | 5 | C0013170 | |
| Disease | Drug abuse | 7.50e-04 | 115 | 182 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 7.50e-04 | 115 | 182 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 7.50e-04 | 115 | 182 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 7.50e-04 | 115 | 182 | 5 | C0013222 | |
| Disease | Drug Dependence | 7.50e-04 | 115 | 182 | 5 | C1510472 | |
| Disease | Substance Dependence | 7.50e-04 | 115 | 182 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 7.50e-04 | 115 | 182 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 7.50e-04 | 115 | 182 | 5 | C0029231 | |
| Disease | anemia (biomarker_via_orthology) | 7.79e-04 | 7 | 182 | 2 | DOID:2355 (biomarker_via_orthology) | |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 7.79e-04 | 7 | 182 | 2 | cv:C0349788 | |
| Disease | Substance abuse problem | 7.80e-04 | 116 | 182 | 5 | C0740858 | |
| Disease | colorectal cancer (is_implicated_in) | 9.43e-04 | 121 | 182 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 1.03e-03 | 8 | 182 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | Sudden Cardiac Arrest | 1.03e-03 | 8 | 182 | 2 | C1720824 | |
| Disease | Sudden Cardiac Death | 1.03e-03 | 8 | 182 | 2 | C0085298 | |
| Disease | chronic obstructive pulmonary disease | MYH9 TPRN PIEZO1 IREB2 IRF1 EMSY BMP6 COL6A3 DSP GALNT12 MICU3 CSNK1A1 | 1.23e-03 | 688 | 182 | 12 | EFO_0000341 |
| Disease | Nonsyndromic genetic hearing loss | 1.27e-03 | 76 | 182 | 4 | cv:C5680182 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 1.32e-03 | 9 | 182 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.32e-03 | 9 | 182 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | prostate carcinoma | ESRP1 HLA-F ATP9B TTK EMSY COL2A1 COL6A3 POLR1A PPFIBP2 LAMC1 PPL LMNA UPF2 PHLPP2 | 1.32e-03 | 891 | 182 | 14 | EFO_0001663 |
| Disease | Focal glomerulosclerosis | 1.42e-03 | 36 | 182 | 3 | C0017668 | |
| Disease | hair colour measurement | PIEZO1 ALX4 SEMA6D MED12L TPRG1 PPFIBP2 PLXDC2 EMC2 EPB41L1 EPB41L2 CPNE7 | 1.60e-03 | 615 | 182 | 11 | EFO_0007822 |
| Disease | cancer antigen 125 measurement | 1.65e-03 | 10 | 182 | 2 | EFO_0010603 | |
| Disease | cortical surface area measurement | ALX4 BMP6 PTPRF BCAP29 ADAMTS9 NAV2 COL2A1 ANO4 ITGA11 LAMC1 GALNT12 CACHD1 STRIP1 PLXDC2 TREH VCAN EPHA3 EPHA7 | 1.73e-03 | 1345 | 182 | 18 | EFO_0010736 |
| Disease | Dystonia | 2.01e-03 | 86 | 182 | 4 | C0013421 | |
| Disease | Tachycardia, Ventricular | 2.01e-03 | 11 | 182 | 2 | C0042514 | |
| Disease | stroke | 2.04e-03 | 144 | 182 | 5 | EFO_0000712 | |
| Disease | Hereditary hearing loss and deafness | 2.16e-03 | 146 | 182 | 5 | cv:C0236038 | |
| Disease | Cleft palate, isolated | 2.22e-03 | 42 | 182 | 3 | C1837218 | |
| Disease | colitis (biomarker_via_orthology) | 2.22e-03 | 42 | 182 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | age at onset, alcohol dependence | 2.22e-03 | 42 | 182 | 3 | EFO_0004847, MONDO_0007079 | |
| Disease | tryptophan betaine measurement | 2.40e-03 | 12 | 182 | 2 | EFO_0021017 | |
| Disease | Charcot-Marie-Tooth Disease | 2.40e-03 | 12 | 182 | 2 | C0007959 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.82e-03 | 13 | 182 | 2 | cv:C4082197 | |
| Disease | Paroxysmal atrial fibrillation | 2.88e-03 | 156 | 182 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 2.88e-03 | 156 | 182 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.88e-03 | 156 | 182 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 3.21e-03 | 160 | 182 | 5 | C0004238 | |
| Disease | Left ventricular noncompaction | 3.28e-03 | 14 | 182 | 2 | C1960469 | |
| Disease | vascular endothelial function measurement | 3.34e-03 | 99 | 182 | 4 | EFO_0803369 | |
| Disease | diverticular disease | 3.55e-03 | 236 | 182 | 6 | EFO_0009959 | |
| Disease | asthma, chronic obstructive pulmonary disease | 3.66e-03 | 50 | 182 | 3 | EFO_0000341, MONDO_0004979 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 3.87e-03 | 51 | 182 | 3 | cv:CN043650 | |
| Disease | obsolete_red blood cell distribution width | MYO1D PIEZO1 TMEM63B CDH23 IRF1 LMBRD2 CDCA2 BMP6 FIG4 RNF10 GAL3ST3 POLR1A ZNF407 SCAMP3 SMG5 PARP10 RBM6 | 4.20e-03 | 1347 | 182 | 17 | EFO_0005192 |
| Disease | vital capacity | MYO1E ATAD5 PIEZO1 GHR BMP6 CCNYL1 RTL9 KDR VWA5B1 COL6A3 MMS22L CYP26B1 DSP CHORDC1 EPB41L2 EPHA3 | 4.28e-03 | 1236 | 182 | 16 | EFO_0004312 |
| Disease | Spondyloepiphyseal Dysplasia | 4.29e-03 | 16 | 182 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.29e-03 | 16 | 182 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.29e-03 | 16 | 182 | 2 | C4551479 | |
| Disease | level of Phosphatidylethanolamine (16:0_20:4) in blood serum | 4.29e-03 | 16 | 182 | 2 | OBA_2045137 | |
| Disease | Abnormal behavior | 4.29e-03 | 16 | 182 | 2 | C0233514 | |
| Disease | Schwartz-Jampel Syndrome | 4.29e-03 | 16 | 182 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.29e-03 | 16 | 182 | 2 | C0025237 | |
| Disease | Alzheimer disease, educational attainment | 4.43e-03 | 247 | 182 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | Benign neoplasm of stomach | 4.84e-03 | 17 | 182 | 2 | C0153943 | |
| Disease | response to radiation, Urinary retention | 4.84e-03 | 17 | 182 | 2 | GO_0009314, HP_0000016 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.84e-03 | 17 | 182 | 2 | C0496905 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 4.84e-03 | 17 | 182 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Uremia | 4.84e-03 | 17 | 182 | 2 | C0041948 | |
| Disease | Carcinoma in situ of stomach | 4.84e-03 | 17 | 182 | 2 | C0154060 | |
| Disease | respiratory symptom change measurement, response to placebo | 4.84e-03 | 17 | 182 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | Van Buchem disease | 4.84e-03 | 17 | 182 | 2 | C0432272 | |
| Disease | Prostatic Neoplasms | 5.10e-03 | 616 | 182 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.10e-03 | 616 | 182 | 10 | C0376358 | |
| Disease | Congenital Fiber Type Disproportion | 5.42e-03 | 18 | 182 | 2 | C0546264 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 5.42e-03 | 18 | 182 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | response to efavirenz, virologic response measurement | 5.55e-03 | 58 | 182 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | Amyotrophic Lateral Sclerosis | 5.55e-03 | 58 | 182 | 3 | C0002736 | |
| Disease | breast cancer (is_marker_for) | 5.92e-03 | 185 | 182 | 5 | DOID:1612 (is_marker_for) | |
| Disease | Osteochondrodysplasias | 6.04e-03 | 19 | 182 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 6.04e-03 | 19 | 182 | 2 | C0013366 | |
| Disease | Cocaine-Related Disorders | 6.04e-03 | 117 | 182 | 4 | C0236736 | |
| Disease | intelligence, self reported educational attainment | 6.04e-03 | 117 | 182 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | X-12063 measurement | 6.05e-03 | 186 | 182 | 5 | EFO_0021283 | |
| Disease | response to cranial radiation therapy, short-term memory | 6.10e-03 | 60 | 182 | 3 | EFO_0004335, EFO_0010950 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSRARYGAGQQDLAT | 61 | Q9H161 | |
| KSVFSSRSLLYVGNR | 1776 | Q96QE3 | |
| LALGSKFRYSGRTQA | 501 | P11171 | |
| KFRYSGRTQAQTRQA | 506 | P11171 | |
| YNLQSALRSAAREFS | 1011 | P78357 | |
| NLSYGRDTDNKAAIR | 426 | O00192 | |
| AATSRYTLNFEAAQK | 156 | P13611 | |
| SSRSFRKLDSRNNAY | 306 | Q5JRM2 | |
| FAGRNLAISQVTTKY | 381 | Q8NHY0 | |
| RGQKRKSGYSLNFSE | 1741 | Q9UIF9 | |
| SKEASRYRDLGNSIV | 856 | Q7Z2Z2 | |
| YSISAGDRSRFQVNA | 726 | Q6V0I7 | |
| RTVQRFYKFNTSLAG | 896 | Q5VU97 | |
| ERKSSLRNAAYFLSN | 346 | Q71F23 | |
| KLFRSQRNLYISGFS | 96 | Q9UHQ4 | |
| YSATRNQGRQKLARF | 321 | Q9Y2X7 | |
| SYRSKNSIRTHGAEN | 301 | Q32M45 | |
| LKNNSTAYSTRGNRI | 541 | Q8TAM1 | |
| GAVRYSFLKTAGNRD | 2646 | Q9H251 | |
| RSFSADNFIGIQRSK | 341 | Q8N7R7 | |
| FRNVEYSSGRNKTFL | 56 | Q9Y235 | |
| AADYAQFRGRRRSKS | 71 | Q9H0I3 | |
| SRKRAGDELAYNSSS | 346 | Q86Y37 | |
| IRAEGNSRFTYTALK | 1421 | P02458 | |
| NFEKSSSVSRYGASQ | 166 | Q6NXG1 | |
| RDYSSGTRCQFQTKF | 16 | Q7Z5G4 | |
| YAQVSSLRNEKRGSS | 641 | Q9HCJ3 | |
| LRSALENSYSKFNRS | 356 | Q8IZ41 | |
| DTAGQERFRSIAKSY | 596 | Q8IZ41 | |
| SVKSTRAVFYNSVNG | 76 | Q5HYI8 | |
| ARDNISYGTNSALKT | 106 | Q8TBF8 | |
| IARNSAAAKYLTNRG | 761 | P48200 | |
| DQSRNKGSSAVRVYR | 96 | P10914 | |
| GYAKANAQTDRVALR | 86 | P30511 | |
| KKSSDRNRGSYSQAA | 331 | P30511 | |
| AAQRNASSYKATTRA | 1561 | Q14573 | |
| RASAGSYISALRVNK | 91 | P28062 | |
| RKNIGSERYTFSFTI | 41 | Q8N635 | |
| YFGENRLRSTQAATQ | 36 | O75439 | |
| LDRDSLYVNGFTQRS | 13586 | Q8WXI7 | |
| SKFRYSGRTQAQTRQ | 391 | Q9H4G0 | |
| RRNSRAYSKNVEGQD | 851 | A0AUZ9 | |
| SYRAFRSENLNLSIK | 1246 | Q14667 | |
| TYSAKLDNARQSAER | 266 | P02545 | |
| YRRSSSVFAGKQGFI | 1256 | Q9NU22 | |
| TFYFRGNETSTNALK | 381 | Q5VTA0 | |
| RFTISRDNAKNSLYL | 86 | P01762 | |
| GRFTISRDNSKNTLY | 86 | A0A075B6Q5 | |
| ALAFDYNQRRKGTNR | 2226 | Q9NZR2 | |
| LGKILSDNAANRYSF | 996 | Q86YW9 | |
| QNRQATFSGRTKSSY | 901 | Q8IWI9 | |
| RFTISRDNAKNSLYL | 86 | P01780 | |
| ARNKRESGKATSYAE | 351 | Q9NQ38 | |
| AERKNEYSRSRSNGT | 751 | Q9NQ38 | |
| GRNIAQREAYSKLLS | 1211 | Q6ZRQ5 | |
| LLQGSGFQSSRREKY | 66 | Q9NR63 | |
| RSAAAAAANRKRAAY | 11 | O43861 | |
| RFTISRDNAKNSLYL | 86 | P01782 | |
| ALYSAQRGLKTNNAA | 2876 | Q2LD37 | |
| LGSKFRYSGRTQAQT | 511 | O43491 | |
| RFTISRDNAKNSLYL | 86 | P01763 | |
| NRRLSSQFENSVYKG | 556 | Q14149 | |
| LGSQYRSVRQKAAGS | 466 | O60437 | |
| QSGKNQGYRDADIRS | 66 | A6NFU8 | |
| KQSLSRLASFIAGYQ | 2826 | Q96JB1 | |
| KLAARNTSAQERYLF | 431 | Q96M96 | |
| RNAFRKALYGTTSET | 391 | P08473 | |
| NRNIRFATYTKENGR | 351 | Q7LBC6 | |
| GSSQLRVNAAFAARY | 6 | Q8N9T8 | |
| AKAARNDVYRAANSL | 491 | P36915 | |
| RFTISRDNAKNSLYL | 86 | A0A0C4DH32 | |
| SNLYRIGQSKVFFRA | 751 | P35579 | |
| YNFASRSIGQDEFKR | 446 | Q86XE3 | |
| FKRLGSSVIYANFNR | 1856 | Q07864 | |
| SYQNARFGSSIASVR | 536 | Q9UKX5 | |
| RQLSFKNSDGSYSVF | 1001 | Q6IE36 | |
| RGFYKSSSQDLQCSR | 281 | Q15375 | |
| SIGYRRSSQLDFQNS | 111 | Q96PQ7 | |
| RFTISRDNAKNSLYL | 86 | A0A0B4J1V1 | |
| YFSNSQRQATKDAGA | 151 | P48741 | |
| KIRRTQSGNFYTDTL | 506 | Q8ND30 | |
| EASERKSALNTRYSN | 516 | Q9NY74 | |
| KYATNRGNLRSAITV | 216 | P29474 | |
| NKGRQDSNSRYSALN | 101 | O00461 | |
| EESRNTLTYAGRAKN | 331 | Q2TAC6 | |
| TFNYNAIDRAKSRGK | 216 | Q8TCG2 | |
| DVLYAKLNARAASSR | 261 | Q96A11 | |
| FSAYGNKTDNTREKR | 266 | Q9P2N4 | |
| NTATALSYGVFRRKD | 206 | Q9Y4L1 | |
| LSYGVFRRKDINTTA | 211 | Q9Y4L1 | |
| ASCFRRSGNYQKALD | 661 | Q13099 | |
| QNYSASSKGERLSAR | 751 | Q13099 | |
| QLCRSSFRYKGNLAS | 331 | Q8N143 | |
| RSKQRNSGNYGEFSE | 231 | P10912 | |
| SFRFSGRTQKQVLDY | 336 | Q9Y4F1 | |
| RARYFLVGSNNAETK | 21 | Q92562 | |
| KGDSNSYNVRRTEGF | 476 | P29317 | |
| SGNNGYVELSFRARK | 226 | Q9UBL6 | |
| RKFFDQYRSGSLSLT | 2541 | P15924 | |
| FVRNNLFTSSAGYRA | 531 | P12111 | |
| NAYSFGRTTIANLKS | 186 | Q5T3F8 | |
| YRLDKFNTASGRNKA | 186 | Q5T764 | |
| QSSSGFLYRRLKTQE | 61 | P22004 | |
| YSRNKALANSVRAAE | 371 | Q8IXK2 | |
| SYTFEKDFSRGLNVR | 256 | Q9UHN6 | |
| ARTAAGYGTNSRKFE | 511 | P29320 | |
| GAERLFRLASNYISK | 236 | Q68D91 | |
| TKATSQFKGYRRRSS | 986 | Q69YH5 | |
| QVSISRSKSYRENGA | 166 | Q96QS3 | |
| ARSVNVKTQALSGYR | 451 | Q9NYP3 | |
| SCENTYSKANRGFIR | 181 | P11047 | |
| LFNSSLSDGAQYVKR | 416 | A6NGE4 | |
| GLFYRSALTQSQSAK | 936 | Q7Z589 | |
| SDSRYLQTNDGNGKR | 461 | Q05BV3 | |
| ASQINRAYQFAGRSK | 261 | Q15006 | |
| FTFTLNGNSRKLDRS | 81 | Q6SJ93 | |
| NGNSRKLDRSVFTAY | 86 | Q6SJ93 | |
| SRSRNALLNGDTKNY | 441 | Q96Q07 | |
| YSGTSDRIRFSVNKR | 386 | Q9BX70 | |
| FLQSKYEGSVRQNSR | 126 | Q12864 | |
| SGARATADQLYIQSK | 696 | D6RIA3 | |
| SYKGSISYRNAARVQ | 86 | Q6SPF0 | |
| HSLYRRTGASFQKAQ | 301 | O14828 | |
| ANQRSRYGLLIKAFS | 1971 | P21817 | |
| TLGSKFRYSGRTQAQ | 401 | Q9Y2J2 | |
| QDNYALTFGNSTRRA | 291 | Q6J272 | |
| TTYIFRLAAKNRAGL | 886 | P10586 | |
| KGVYFARRASLSVQD | 916 | Q53GL7 | |
| QRRISSAKFLGELYN | 866 | Q9HAU5 | |
| ARDKLAFTQSRAASY | 1036 | Q16363 | |
| ENIASNYFRSKRASQ | 946 | Q9P2E2 | |
| NYFRSKRASQILSTD | 951 | Q9P2E2 | |
| LSKYRSRSADGAKNY | 211 | Q96CV9 | |
| LYFNTQEKSARRRGD | 41 | Q92521 | |
| KSFLRRSQGIYDSLS | 1216 | Q8NET4 | |
| YDTSRQATAFGLLKA | 2216 | O75691 | |
| GRTSKRQSNETYRDA | 1096 | P78332 | |
| FETATRAALQKRYGS | 171 | P62745 | |
| LLTSRDQSYQFKTGA | 126 | Q9GZN7 | |
| NTLLRRGAFLSYSQK | 1081 | O95602 | |
| KFTLQDSRTNTAYVG | 101 | Q96CS7 | |
| KNERLRAAFGISDSY | 131 | Q9UQ35 | |
| RAGSKQYSAAIAFTL | 371 | Q9UPR3 | |
| RKITSYFLNEGSQAR | 266 | O75792 | |
| GATTFIYNRAVKNTR | 116 | Q6XZB0 | |
| SDVNTNRSAFKYTRA | 626 | Q68DH5 | |
| NRSAFKYTRANNRTE | 631 | Q68DH5 | |
| GFSSKSRRNSFAYDV | 11 | Q96RN1 | |
| REDKNLTGTARYASI | 176 | P48729 | |
| TFYGLRQQAEKDSAS | 1061 | Q99707 | |
| ANASRFINTESGRYV | 831 | Q8IVL1 | |
| SRNSTVRYFDNGTAL | 211 | Q6UX71 | |
| NRYKQSRDISTLNSG | 501 | P04843 | |
| FNRNQRKDSEGYSES | 51 | Q5VSL9 | |
| GASTIDFLKRYASNT | 11 | Q7Z333 | |
| SINFYKRRGASDLSS | 136 | P21673 | |
| YINLEGTRKARNTFS | 306 | Q13017 | |
| EGHRQKSEFYNRTAS | 966 | Q86SQ0 | |
| GSQEAQFYTLRTAKA | 386 | Q8IYS1 | |
| LSNAISRLKDTGYQR | 101 | Q9HCE7 | |
| AAGRAYNISVFSVKR | 971 | Q8TER0 | |
| RRKTSDFNTFLAQEG | 196 | Q9UHD1 | |
| RRTANIKSIGYSDLF | 556 | P29973 | |
| SGNRRTANIKSLGYS | 426 | Q8IV77 | |
| DKFSNSNRYKRRHTG | 86 | Q9UII5 | |
| GKSYSQSSNLFRHQR | 341 | P17028 | |
| YQRLADAFNKLTASS | 1106 | Q9C0E2 | |
| RYFSLSDKDANSNGV | 131 | Q96BR9 | |
| EVKRRQYSLAFSSAG | 206 | Q6ZVD8 | |
| TKAYSRRGAARFALQ | 201 | Q9H6T3 | |
| ASFDEFGNSKYQNRR | 91 | Q00403 | |
| ARSLRLQKQFAGYSE | 321 | Q12788 | |
| NSSGSKRYNRKRELS | 56 | Q8N5U6 | |
| FRKRDSQGTYSSRDA | 846 | Q9C0C2 | |
| RFLLRYFSQSDKSQG | 66 | P12018 | |
| SFIGNRNKLGYSLAR | 256 | Q6ZUI0 | |
| SNFYSRLGNDSQATK | 361 | O43280 | |
| DGYSVSRQAQAKFSL | 81 | A0A075B6N3 | |
| NGYNVSRLNKREFSL | 81 | A0A0K0K1D8 | |
| NNSNKRRRFSGTAVY | 646 | Q6AHZ1 | |
| EGRYSLNFQKARKSA | 81 | A0A0A6YYC5 | |
| KGFSYGSNLRTHQRL | 691 | Q9UJW7 | |
| FGKFSNSNRDKTRYT | 166 | Q96JC4 | |
| ADKSIYFRSAQQGSD | 601 | O43379 | |
| QLSYSDNQASAKRGS | 136 | Q86T82 | |
| GKRQASRAFSLYANI | 101 | Q9GZM5 | |
| ARRSDFLQKTGSNSF | 191 | Q4KMQ1 | |
| SRGQTTKARFLYGEN | 231 | P33981 | |
| DSSRQRLYNTRGKSL | 121 | P17031 | |
| SQGASSSQARRYEKF | 826 | Q8N5H7 | |
| FGNLSTYLRSKRNEF | 921 | P35968 | |
| ASRGFALYNAANLKS | 1321 | Q92508 | |
| YSFGRFDSSIIRIKN | 1351 | Q9C0G0 | |
| ALSKRSLAARGYVQD | 21 | O60294 | |
| SQDQKLYSSAEFGRR | 291 | Q8WY21 | |
| RQTNVALFADGKLYS | 171 | Q8NFY4 | |
| TSLERQRGYHKNSSQ | 956 | Q8NFY4 | |
| AKSVRNYTQEASLGA | 691 | Q99959 | |
| FATAYQGTRARSDNT | 31 | Q5W0B7 | |
| GSNRRYQVSALHTSK | 876 | Q5TIE3 | |
| AKTNRNDNSSRFGKY | 151 | O94832 | |
| TVRNNNSSRFGKYFE | 161 | Q12965 | |
| ARTNRNHNSSRFGKY | 151 | B0I1T2 | |
| KFTDRRTDQFNGYSK | 1686 | Q9NR99 | |
| VLYNASGFLAKNRDT | 836 | Q8NEV4 | |
| TTRNDNSSRFGKYIE | 211 | Q9Y4I1 | |
| TTRNDNSSRFGKYIQ | 211 | Q9ULV0 | |
| RNDNSSRFGKYTEIS | 211 | Q9NQX4 | |
| LRSRYSVASFKFDAG | 451 | Q6NSJ0 |